Ionis Pharmaceuticals Inc (IONS)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current IONS market cap is 6.12B. The company's latest EPS is USD -2.5052 and P/E is -16.70.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 188.41M | 144.21M | 324.51M | 119.5M | 225.25M |
| Operating Income | -90.2M | -143.26M | -6.12M | -149.51M | -66.09M |
| Net Income | -85.29M | -147.41M | -9.26M | -142.8M | -66.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.12B | 729.26M | 810.46M | 587.37M | 787.65M |
| Operating Income | 365.88M | -172.08M | -30.19M | -410.19M | -353.73M |
| Net Income | 294.15M | -451.29M | -28.6M | -269.72M | -366.29M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.97B | 2.93B | 2.99B | 2.76B | 2.69B |
| Total Liabilities | 2.54B | 2.62B | 2.6B | 2.47B | 2.43B |
| Total Equity | 428.3M | 315.46M | 386.69M | 296.52M | 263.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 3.23B | 2.39B | 2.61B | 2.53B | 2.99B |
| Total Liabilities | 1.55B | 1.55B | 1.84B | 1.96B | 2.6B |
| Total Equity | 1.68B | 843.35M | 771.74M | 572.89M | 386.69M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -231.36M | -340.38M | -307.51M | -149.94M | -269.82M |
| Investing | -256.13M | -187.41M | -214.13M | 76.11M | 138.56M |
| Financing | 635.63M | 603.36M | 644.08M | 23.57M | 26.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 345.72M | 35.89M | 30.8M | -274.37M | -307.51M |
| Investing | -41.27M | 274.48M | 194.91M | -262.64M | -214.13M |
| Financing | 100.02M | -596.61M | 245.93M | -55.3M | 644.08M |
| Market Cap | 6.12B |
| Price to Earnings Ratio | -16.70 |
| Price to Sales Ratio | 7.76 |
| Price to Cash Ratio | 15.32 |
| Price to Book Ratio | 15.82 |
| Dividend Yield | - |
| Shares Outstanding | 146.21M |
| Average Volume (1 week) | 1.84M |
| Average Volume (1 Month) | 2.21M |
| 52 Week Change | -1.95% |
| 52 Week High | 54.4446 |
| 52 Week Low | 35.95 |
| Spread (Intraday) | 2.68 (6.12%) |
| Company Name | Ionis Pharmaceuticals Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.isispharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
